HCPCS Code Q5128
Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg
| Short Description | Inj, cimerli, 0.1 mg |
|---|---|
| Year | 2026 |
| Coverage Code | C = Carrier judgment |
| Action Code | N = No maintenance for this code |
| Action Effective Date | April 01, 2023 |
| Code Added Date | April 01, 2023 |
| Pricing Indicator | 51 = Drugs |
| Type of Service | 1 = Medical care |